Trustees of The University of Pennsylvania Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAPT
RAPT Therapeutics
RAPT
|
+$167K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$28.7M |
| 2 |
Coursera
COUR
|
+$3.28M |
| 3 |
Ginkgo Bioworks
DNA
|
+$1.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 40.92% |
| 2 | Consumer Staples | 40.75% |
| 3 | Financials | 18.11% |
| 4 | Healthcare | 0.22% |
Similar funds
Trustees of The University of Pennsylvania's Q2 2022 Portfolio in Review
As of Q2 2022, Trustees of The University of Pennsylvania held 7 positions worth $82M, down 38% from $132M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trustees of The University of Pennsylvania withdrew a net $33.4M in Q2 2022, closing 2 positions and reducing 1 holding. Its most notable exit was Keurig Dr Pepper, an estimated $28.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 41% of assets, up from 32% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Trustees of The University of Pennsylvania opened a new position in RAPT Therapeutics worth $183K.
- Trustees of The University of Pennsylvania's largest Q2 2022 buy was RAPT Therapeutics: 1,254 shares worth $183K.
- Trustees of The University of Pennsylvania's biggest Q2 2022 reduction was Coursera, cutting an estimated $3.28M.
- Trustees of The University of Pennsylvania fully exited Keurig Dr Pepper in Q2 2022, selling an estimated $28.7M.
- Trustees of The University of Pennsylvania's ten largest holdings make up 100% of its $82M portfolio in Q2 2022.
- Trustees of The University of Pennsylvania opened 1 new position and closed 2 in Q2 2022.
- Trustees of The University of Pennsylvania's portfolio value fell 38% quarter-over-quarter to $82M.
Based on Trustees of The University of Pennsylvania's 13F filing for Q2 2022, filed 12 Aug 2022.